• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Humoral and cellular immunity to Plasmodium falciparum merozoite surface protein 1 and protection from infection with blood-stage parasites.对恶性疟原虫裂殖子表面蛋白 1 的体液和细胞免疫与对血期寄生虫感染的保护作用。
J Infect Dis. 2013 Jul;208(1):149-58. doi: 10.1093/infdis/jit134. Epub 2013 Mar 28.
2
Temporal stability of naturally acquired immunity to Merozoite Surface Protein-1 in Kenyan adults.肯尼亚成年人对裂殖子表面蛋白-1自然获得性免疫的时间稳定性。
Malar J. 2009 Jul 16;8:162. doi: 10.1186/1475-2875-8-162.
3
Longevity of Genotype-Specific Immune Responses to Plasmodium falciparum Merozoite Surface Protein 1 in Kenyan Children from Regions of Different Malaria Transmission Intensity.肯尼亚不同疟疾传播强度地区儿童对恶性疟原虫裂殖子表面蛋白1的基因型特异性免疫反应的持久性
Am J Trop Med Hyg. 2016 Sep 7;95(3):580-7. doi: 10.4269/ajtmh.15-0710. Epub 2016 Aug 1.
4
Allele specificity of gamma interferon responses to the carboxyl-terminal region of Plasmodium falciparum merozoite surface protein 1 by Kenyan adults with naturally acquired immunity to malaria.肯尼亚成年人对疟疾自然获得性免疫中γ干扰素对恶性疟原虫裂殖子表面蛋白 1 羧基末端区的等位基因特异性反应。
Infect Immun. 2010 Oct;78(10):4431-41. doi: 10.1128/IAI.00415-10. Epub 2010 Aug 9.
5
Immunity to recombinant plasmodium falciparum merozoite surface protein 1 (MSP1): protection in Aotus nancymai monkeys strongly correlates with anti-MSP1 antibody titer and in vitro parasite-inhibitory activity.对重组恶性疟原虫裂殖子表面蛋白1(MSP1)的免疫:绢毛猴体内的保护作用与抗MSP1抗体滴度及体外寄生虫抑制活性密切相关。
Infect Immun. 2006 Aug;74(8):4573-80. doi: 10.1128/IAI.01679-05.
6
Results from tandem Phase 1 studies evaluating the safety, reactogenicity and immunogenicity of the vaccine candidate antigen Plasmodium falciparum FVO merozoite surface protein-1 (MSP1(42)) administered intramuscularly with adjuvant system AS01.来源于评估候选抗原恶性疟原虫 FVO 裂殖子表面蛋白-1(MSP1(42))经肌内注射与佐剂系统 AS01 联合使用的安全性、反应原性和免疫原性的两阶段 1 期研究结果。
Malar J. 2013 Jan 23;12:29. doi: 10.1186/1475-2875-12-29.
7
Immunoglobulin G subclass-specific responses against Plasmodium falciparum merozoite antigens are associated with control of parasitemia and protection from symptomatic illness.针对恶性疟原虫裂殖子抗原的免疫球蛋白G亚类特异性反应与控制疟原虫血症及预防症状性疾病相关。
Infect Immun. 2009 Mar;77(3):1165-74. doi: 10.1128/IAI.01129-08. Epub 2009 Jan 12.
8
Age-related differences in naturally acquired T cell memory to Plasmodium falciparum merozoite surface protein 1.年龄相关的自然获得性 T 细胞记忆对恶性疟原虫裂殖子表面蛋白 1 的差异。
PLoS One. 2011;6(9):e24852. doi: 10.1371/journal.pone.0024852. Epub 2011 Sep 16.
9
Impact of pre-existing MSP1(42)-allele specific immunity on potency of an erythrocytic Plasmodium falciparum vaccine.预先存在的 MSP1(42)-等位基因特异性免疫对红内期疟原虫疫苗效力的影响。
Malar J. 2012 Sep 7;11:315. doi: 10.1186/1475-2875-11-315.
10
Plasmodium falciparum merozoite surface antigen-specific cytophilic IgG and control of malaria infection in a Beninese birth cohort.恶性疟原虫裂殖子表面抗原特异性细胞亲合 IgG 与贝宁出生队列中疟疾感染的控制。
Malar J. 2019 Jun 11;18(1):194. doi: 10.1186/s12936-019-2831-x.

引用本文的文献

1
The role of naturally acquired antimalarial antibodies in subclinical Plasmodium spp. infection.天然获得的抗疟抗体在亚临床疟原虫感染中的作用。
J Leukoc Biol. 2022 May;111(5):1097-1105. doi: 10.1002/JLB.5MR1021-537R. Epub 2022 Jan 20.
2
Recombinant DBL2β-PfEMP1 of the Indonesian induces immune responses in Wistar rats.印度尼西亚重组DBL2β-PfEMP1在Wistar大鼠中诱导免疫反应。
J Taibah Univ Med Sci. 2021 Jan 15;16(3):422-430. doi: 10.1016/j.jtumed.2020.12.007. eCollection 2021 Jun.
3
Increased investment in gametocytes in asymptomatic Plasmodium falciparum infections in the wet season.在雨季无症状的恶性疟原虫感染中,配子体的投入增加。
BMC Infect Dis. 2021 Jan 9;21(1):44. doi: 10.1186/s12879-020-05761-6.
4
T Helper Plasticity Is Orchestrated by STAT3, Bcl6, and Blimp-1 Balancing Pathology and Protection in Malaria.辅助性T细胞可塑性由STAT3、Bcl6和Blimp-1调控,在疟疾中平衡病理状态与保护作用。
iScience. 2020 Jul 24;23(7):101310. doi: 10.1016/j.isci.2020.101310. Epub 2020 Jun 24.
5
Using two phases of the CD4 T cell response to blood-stage murine malaria to understand regulation of systemic immunity and placental pathology in Plasmodium falciparum infection.利用 CD4 T 细胞对血期疟原虫的两个反应阶段来理解恶性疟原虫感染中系统性免疫和胎盘病理的调节。
Immunol Rev. 2020 Jan;293(1):88-114. doi: 10.1111/imr.12835.
6
Understanding Asymptomatic Infections: A Proposition for a Transcriptomic Approach.理解无症状感染:一种转录组学方法的提议。
Front Immunol. 2019 Oct 15;10:2398. doi: 10.3389/fimmu.2019.02398. eCollection 2019.
7
Interferon- and Interleukin-10 Responses during Clinical Malaria Episodes in Infants Aged 0-2 Years Prenatally Exposed to : Tanzanian Birth Cohort.0至2岁婴儿产前暴露于疟疾的临床疟疾发作期间的干扰素和白细胞介素-10反应:坦桑尼亚出生队列研究
J Trop Med. 2018 Jul 30;2018:6847498. doi: 10.1155/2018/6847498. eCollection 2018.
8
Genetic diversity of merozoite surface protein-1 C-terminal 42 kDa of Plasmodium falciparum (PfMSP-1) may be greater than previously known in global isolates.恶性疟原虫裂殖子表面蛋白-1 羧基末端 42kDa 区(PfMSP-1)的遗传多样性在全球分离株中可能大于以往所知。
Parasit Vectors. 2018 Aug 6;11(1):455. doi: 10.1186/s13071-018-3027-x.
9
Sero-catalytic and Antibody Acquisition Models to Estimate Differing Malaria Transmission Intensities in Western Kenya.肯尼亚西部基于血清学和抗体获得模型估计不同疟疾传播强度。
Sci Rep. 2017 Dec 4;7(1):16821. doi: 10.1038/s41598-017-17084-9.
10
Interferon- responses to vaccine candidate antigens decrease in the absence of malaria transmission.在没有疟疾传播的情况下,对候选疫苗抗原的干扰素反应会降低。
PeerJ. 2017 Jan 10;5:e2855. doi: 10.7717/peerj.2855. eCollection 2017.

本文引用的文献

1
The dynamics of naturally acquired immunity to Plasmodium falciparum infection.疟原虫感染自然获得性免疫的动力学。
PLoS Comput Biol. 2012;8(10):e1002729. doi: 10.1371/journal.pcbi.1002729. Epub 2012 Oct 18.
2
Broadly reactive antibodies specific for Plasmodium falciparum MSP-1(19) are associated with the protection of naturally exposed children against infection.广谱针对恶性疟原虫 MSP-1(19)的抗体与自然暴露儿童免受感染的保护有关。
Malar J. 2012 Aug 21;11:287. doi: 10.1186/1475-2875-11-287.
3
A Plasmodium-encoded cytokine suppresses T-cell immunity during malaria.疟原虫编码的细胞因子在疟疾期间抑制 T 细胞免疫。
Proc Natl Acad Sci U S A. 2012 Jul 31;109(31):E2117-26. doi: 10.1073/pnas.1206573109. Epub 2012 Jul 9.
4
Immunogenicity of self-associated aggregates and chemically cross-linked conjugates of the 42 kDa Plasmodium falciparum merozoite surface protein-1.自身相关聚集物和化学交联的疟原虫裂殖子表面蛋白 1 42kDa 片段的免疫原性。
PLoS One. 2012;7(6):e36996. doi: 10.1371/journal.pone.0036996. Epub 2012 Jun 4.
5
T cell-derived IL-10 and its impact on the regulation of host responses during malaria.T 细胞衍生的白细胞介素-10 及其对疟疾期间宿主反应调控的影响。
Int J Parasitol. 2012 May 15;42(6):549-55. doi: 10.1016/j.ijpara.2012.03.010. Epub 2012 Apr 24.
6
Age-related differences in naturally acquired T cell memory to Plasmodium falciparum merozoite surface protein 1.年龄相关的自然获得性 T 细胞记忆对恶性疟原虫裂殖子表面蛋白 1 的差异。
PLoS One. 2011;6(9):e24852. doi: 10.1371/journal.pone.0024852. Epub 2011 Sep 16.
7
T cell epitope regions of the P. falciparum MSP1-33 critically influence immune responses and in vitro efficacy of MSP1-42 vaccines.恶性疟原虫 MSP1-33 的 T 细胞表位区域对免疫反应和 MSP1-42 疫苗的体外疗效有重要影响。
PLoS One. 2011;6(9):e24782. doi: 10.1371/journal.pone.0024782. Epub 2011 Sep 13.
8
A field trial to assess a blood-stage malaria vaccine.评估一种血阶段疟疾疫苗的现场试验。
N Engl J Med. 2011 Sep 15;365(11):1004-13. doi: 10.1056/NEJMoa1008115.
9
Phase Ia clinical evaluation of the Plasmodium falciparum blood-stage antigen MSP1 in ChAd63 and MVA vaccine vectors.恶性疟原虫血期抗原 MSP1 在 ChAd63 和 MVA 疫苗载体中的 I 期临床评估。
Mol Ther. 2011 Dec;19(12):2269-76. doi: 10.1038/mt.2011.176. Epub 2011 Aug 23.
10
The stability and complexity of antibody responses to the major surface antigen of Plasmodium falciparum are associated with age in a malaria endemic area.在疟疾流行地区,对恶性疟原虫主要表面抗原的抗体反应的稳定性和复杂性与年龄有关。
Mol Cell Proteomics. 2011 Nov;10(11):M111.008326. doi: 10.1074/mcp.M111.008326. Epub 2011 Aug 8.

对恶性疟原虫裂殖子表面蛋白 1 的体液和细胞免疫与对血期寄生虫感染的保护作用。

Humoral and cellular immunity to Plasmodium falciparum merozoite surface protein 1 and protection from infection with blood-stage parasites.

机构信息

Center for Global Health and Diseases, Case Western Reserve University, Cleveland, Ohio, USA.

出版信息

J Infect Dis. 2013 Jul;208(1):149-58. doi: 10.1093/infdis/jit134. Epub 2013 Mar 28.

DOI:10.1093/infdis/jit134
PMID:23539744
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3666139/
Abstract

BACKGROUND

Acquired immunity to malaria develops with increasing age and repeated infections. Understanding immune correlates of protection from malaria would facilitate vaccine development and identification of biomarkers that reflect changes in susceptibility resulting from ongoing malaria control efforts.

METHODS

The relationship between immunoglobulin G (IgG) antibody and both interferon γ (IFN-γ) and interleukin 10 (IL-10) responses to the 42-kD C-terminal fragment of Plasmodium falciparum merozoite surface protein 1 (MSP142) and the risk of (re)infection were examined following drug-mediated clearance of parasitemia in 94 adults and 95 children in an area of holoendemicity of western Kenya.

RESULTS

Positive IFN-γ enzyme-linked immunosorbent assay (ELISA) and enzyme-linked immunosorbent spot assay (ELISPOT) responses to MSP142 3D7 were associated with delayed time to (re)infection, whereas high-titer IgG antibodies to MSP142 3D7 or FVO alleles were not independently predictive of the risk of (re)infection. When IFN-γ and IL-10 responses were both present, the protective effect of IFN-γ was abrogated. A Cox proportional hazard model including IFN-γ, IL-10, MSP142 3D7 IgG antibody responses, hemoglobin S genotype, age, and infection status at baseline showed that the time to blood-stage infection correlated positively with IFN-γ responses and negatively with IL-10 responses, younger age, and asymptomatic parasitemia.

CONCLUSIONS

Evaluating combined allele-specific cellular and humoral immunity elicited by malaria provides a more informative measure of protection relative to evaluation of either measure alone.

摘要

背景

疟疾获得性免疫随年龄增长和重复感染而增强。了解疟疾保护性免疫相关因素有助于疫苗开发和鉴定反映因持续疟疾控制措施而导致的易感性变化的生物标志物。

方法

在肯尼亚西部疟疾高度流行地区,94 名成年人和 95 名儿童经药物清除疟原虫后,研究了 IgG 抗体以及 IFN-γ和白细胞介素 10(IL-10)对恶性疟原虫裂殖体表面蛋白 1(MSP142)42kD C 端片段的反应与(再)感染风险之间的关系。

结果

MSP142 3D7 的 IFN-γ酶联免疫吸附试验(ELISA)和酶联免疫斑点试验(ELISPOT)阳性反应与(再)感染的延迟时间相关,而 MSP142 3D7 或 FVO 等位基因的高滴度 IgG 抗体与(再)感染风险无独立相关性。当 IFN-γ和 IL-10 反应均存在时,IFN-γ的保护作用被消除。包含 IFN-γ、IL-10、MSP142 3D7 IgG 抗体反应、血红蛋白 S 基因型、年龄和基线时感染状态的 Cox 比例风险模型显示,血期感染时间与 IFN-γ反应呈正相关,与 IL-10 反应呈负相关,与年龄较小和无症状性疟原虫血症相关。

结论

评估疟疾诱导的特定等位基因的细胞和体液免疫联合反应相对于单独评估任何一种反应提供了更有信息的保护措施衡量指标。